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1. Introduction 
Percutaneous valve implantation is an innovative, successful alternative to open-heart 
surgery for the treatment of both pulmonary and aortic heart valve dysfunction (Bonhoeffer 
et al., 2000; Cribier et al., 2002; Leon et al., 2011; Lurz et al., 2008; McElhinney DB et al., 2010; 
Rodes-Cabau et al., 2010; Smith et al., 2011; Vahanian et al., 2008). However, this minimally-
invasive procedure still presents limitations related to device design: stent fracture, 
availability to a limited group of patients with very specific anatomy and conditions, and 
positioning and anchoring issues (Delgado et al., 2010; Nordmeyer et al., 2007; Schievano et 
al., 2007a). Computational simulations (Taylor & Figueroa, 2009), together with advanced 
cardiovascular imaging techniques can be used to help understand these limitations in order 
to guide the optimisation process for new device designs, to improve the success of 
percutaneous valve implantation, and ultimately to broaden the range of patients who could 
benefit from these procedures.  
In this Chapter, we review the applications of finite element (FE) analyses to study 
percutaneous heart valve devices. The current percutaneous pulmonary valve implantation 
(PPVI) device is first presented: FE analyses were used to understand stent fractures in the 
patient specific setting and to study a potential solution to this problem. The shortcomings 
of the present PPVI stent have created a need for the next generation device. The 
optimisation study performed on this device using FE analyses, together with the first-in-
man clinical application are described. The last part of this Chapter focuses on transcatheter 
aortic valve implantation (TAVI) and the innovative use of FE analyses to model patient 
specific implantation procedures. Computational analyses were used as a tool to assess the 
feasibility and safety of TAVI in patients who are currently considered unsuitable for this 
procedure.  
2. Percutaneous pulmonary valve implantation 
In the late 1990’s, Professor Philipp Bonhoeffer developed a new technique of heart valve 
replacement that avoided the need for surgery (Bonhoeffer et al., 2000). This was based on 
the concept that a heart valve sewn inside a stent could be reduced in size, by crimping it 
onto a balloon catheter, and then introduced through a peripheral vessel to the desired 
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implantation site in the heart (Fig. 1). Inflation of the balloon deployed the valved stent and 
anchored it within the old dysfunctional valve. Over the last 11 years, this simple technique 
has shown a marked learning curve with safety and efficacy improvements that have led to 
CE mark in 2006, Food and Drug Administration (FDA) approval in 2010, and successful, 
worldwide clinical use of this procedure in the pulmonary position (>2,000 implants to date) 
and thousands of implants in the aortic position.  
 
Fig. 1. a) Current PPVI device: Melody™, Medtronic, MN USA. Pulmonary angiograms b) 
pre- and c) post-PPVI in a patient. In this patient significant pulmonary regurgitation 
(contrast in the anterior right ventricle in b) has been completely abolished 
2.1 Current device 
The current PPVI device (Melody™, Medtronic, MN, USA) is constructed with a valve from 
a bovine jugular vein, sewn into a balloon-expandable, platinum-10%iridium stent (Fig. 1a). 
The stent is created by 6 wires, formed into a zig-zag shaped pattern, and welded together. 
Since the platinum welds were prone to fracture, this component of the PPVI was modified 
during the early clinical experience by introducing a gold braising process to reinforce the 
crowns. The bovine vein is attached to the stent by sutures around the proximal and distal 
rings and at each strut intersection. Bovine jugular venous valves are available only up to 22 
mm of diameter, thus limiting the use of this minimally-invasive technique to those patients 
who have a small implantation site. During the procedure in the catheterisation laboratory, 
the valved stent assembly is hand-crimped to a size of 6 mm onto a custom made delivery 
system, before being re-expanded inside the patient’s implantation site. 
2.1.1 Understanding and predicting stent fractures  
During the development phases of the current PPVI device, simple bench and animal 
experiments were performed as part of routine preclinical testing. These in-vitro and in-vivo 
experiments predicted valve degeneration with no stent fracturing. However, in our clinical 
practice, the opposite occurred – good valve function, ~20% stent fractures (Nordmeyer et 
al., 2007). These discrepancies were most likely due to the fact that in patients, the in-vivo 
loading conditions could not be correctly reproduced with experimental set-ups, where the 
boundary conditions are simplified and not representative of the real situation. For example, 
in the bench experiments for fatigue assessment, PPVI stents were placed in distensible 
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cylindrical tubes. However, the final shape of the PPVI stent in situ is a long way away from 
being uniformly cylindrical.  
In order to better understand and predict the stent mechanical performance and durability, 
the implantation site morphology has to be included into in-vitro testing. To demonstrate 
this concept, and to test that computational analysis can indeed predict where stent fractures 
will occur, we reproduced patient-specific procedures using computational analysis.  
Five patients (I to V) who underwent PPVI and experienced fracture between 1 and 6 
months after implantation were selected (Cosentino et al., 2011). Biplane, orthogonal, 
fluoroscopy images (Axiom Artis Flat Detector system, Siemens Medical Systems, Germany) 
from the actual PPVI procedures of these patients were used to reconstruct the 3D geometry 
of the stents in-situ (Rhinoceros CAD software, McNeel, WA, USA; Schievano et al., 2010b) 
at the end of balloon inflation, and at early systole and diastole (Fig. 2). From these 
reconstructions, the displacements of every strut junction of the stent from the end of 
balloon inflation through systole and diastole were calculated. Circumferential, radial and 
longitudinal asymmetries were measured for each time step and every patient. The stent 
expanded into the patients’ implantation sites resembled the outline of their arterial walls, 
resulting in asymmetry in all directions (Fig. 3top). In particular, some of the stent struts 
were at an early stage of expansion, while others were over-deployed compared to a 
uniformly deployed stent in a cylinder. The most expanded cells were located in 
correspondence to the fracture positions as detected from x-rays images in the patients. 
Furthermore, in all studied patients, the stents were non-circular in cross-section and the 
terminal rings were more expanded if compared to the central portions. 
 
Fig. 2. Superimposition of the stent fluoroscopy reconstructions for one patient at the end of 
balloon inflation, systole, and diastole compared to the initial crimped configuration (lateral 
and top views) 
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Fig. 3. Stent fluoroscopy reconstructions for the analysed patients at diastole (top panel) and 
corresponding FE deployed configurations (bottom panel) 
A FE model of the crimped stent in the catheter was created, with a structured hexahedral 
mesh of 119,360 elements to model the platinum-iridium wires. To reproduce the golden 
coverings, an additional set of elements was modelled around the junctions and a structured 
hexahedral mesh was generated using 36,320 elements. Stent geometrical and material 
properties were provided by the manufacturer (Table 1; Schievano et al., 2007c).  
PPVI stent 
Geometry  
Wire diameter 0.33 mm 
Crimped configuration internal diameter 4.00 mm 
Crimped configuration overall length 34.32 mm 
Central zig-zag segment length 5.78 mm 
Terminal zig-zag segment length 5.62 mm 
Platinum-10% Iridium  
Young modulus 224 GPa 
Poisson ratio 0.37 
Yield stress 285 MPa 
Ultimate strength 875 MPa 
Fatigue endurance strength 263 MPa 
Gold  
Young modulus 80 GPa 
Poisson ratio 0.42 
Table 1. Stent geometrical and material properties 
www.intechopen.com
 Finite Element Analysis to Study Percutaneous Heart Valves 171 
Patient-specific stent deployments were replicated in Abaqus/Standard (Simulia, RI, USA) 
using nodal displacement boundary conditions (Fig. 3bottom). These displacements were 
those previously calculated from fluoroscopy reconstructions and were applied to the 
central node of each stent strut junction. Three displacement steps were performed to 
account for the full loading history of the stent and potential residual stresses: the first step 
resulted in the stent deployment from its initial crimped status to the end of balloon 
inflation; the second and the third steps replicated a cardiac cycle from systole to diastole. 
The elements surrounding the nodes of displacement application were subtracted from the 
model in the analysis of stress outcomes because they resulted distorted due to the type of 
displacement condition adopted. This was considered acceptable as fractures at the strut 
junctions have not been reported for the current stent after golden reinforcements were 
introduced.  
 
Fig. 4. Comparison of the stress distribution and Goodman diagrams between the stent 
deployed in a cylindrical configuration, as performed during conventional preclinical 
testing, and the stent deployed according to individual in-situ geometry from 1 of the 
studied patients. Goodman diagrams are a graphical representation of fatigue analysis  
(σm and σa = mean and alternating stresses, while Sult and Se = material ultimate and fatigue 
endurance strengths) 
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Stresses in the stents after deployment in patients’ configurations were higher if compared 
to the same stent uniformly expanded in a cylindrical geometry as done during 
conventional preclinical testing, and, therefore, the risk of reaching the endurance limit of 
the material was higher (Fig. 4). The highest stresses occurred close to the strut junctions, 
which were the most highly bent portions of the device. The peak σVM was reached during 
diastole in every patient, and its values ranged between 516.1 and 612.8 MPa. 
A fatigue analysis was performed by applying the Goodman method (Beden et al., 2009; 
Marrey et al., 2006) and the Sines criterion (Sines & Ohgi, 1981). The first uses a graphical 
approach to relate alternating stress (σa) and mean stress (σm) during the cardiac cycle with 
the material strength limits (Fig. 4), where σa and σm are calculated as follows: 
2
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J and σH,m are the amplitude of the mean square root of the second deviatoric 
stress invariant and the hydrostation pressure, respectively.  
During the cyclic loading condition, the stent in the patients worked at high σm and σa, if 
compared to a uniformly deployed stent, thus indicating a high number of areas at risk of 
fatigue failure as shown by the Goodman distributions (Fig. 4). The portions at highest 
potential for fracture were non-uniformly distributed amongst the different studied cases, 
with highest values in the areas close to the strut junctions, where indeed such fractures  
 
Fig. 5. X-ray image of the stent in-vivo in 1 of the analysed patients at 3 months follow-up 
compared to the Sines stress map in the corresponding patient FE simulation with areas at 
highest risk for fracture highlighted in red   
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occurred in the patients (Fig. 5). The Sines criterion predicted fractures in every case, with 
the most stressed regions in 3 cases close to the strut intersections between the first and the 
second ring from the proximal end; in one case it was at the lowest terminal crown and in 
the last patient it was detected between the second and the third crown.  
Reproducing patient-specific FE analysis with more realistic loading conditions can provide 
more accurate information regarding the stent mechanical performance and prediction of 
fatigue life compared to the conventional bench methodologies/FE analyses/ of 
free/cylindrically constrained expansion. Indeed, this computational analysis predicted 
failure and the locations of fractures were similar to the sites where the patients ultimately 
had stent damage. 
2.1.2 Stent-in-stent as a potential solution to stent fractures 
FE analysis can also give insight into improved clinical management. This is demonstrated by 
a FE analysis of stent mechanical performance for various combinations of stent designs. 
Inserting a separate stent into the pulmonary artery prior to the PPVI device (stent-in-stent 
technique, Nordmeyer et al., 2008) may reduce valved stent fractures. An optimised 
combination of different stent mechanical properties can help increase the strength of the 
device structure while at the same time reduce the stresses. This was computationally tested 
by expanding 2 PPVI stents 1 inside the other (Schievano et al, 2007c). The mechanical 
performance of the coupled device was compared with that of a single valved stent, expanded 
and cyclic loaded at the same conditions. The stresses in the outer stent of the coupled device 
were similar to those of the single valved stent. However, the stresses in the coupled device 
inner stent, which holds the valve, were lower when compared to the stresses in the single 
valved stent (Fig. 6), thus decreasing the risk of fracture for the valved stent. 
 
Fig. 6. Stress distributions in the single valved stent and in the inner valved stent when 2 
devices are coupled together (stent-in-stent)  
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The implantation of a previous device before the valved one acts functionally to bolster the 
vessel and reduce the stresses on the stent. This information, in combination with the 
computational modelling described above, suggests that pre-stenting may ensure the 
integrity of the valved device, thus enhancing the success of the percutaneous procedure. 
Indeed this is the case when we look at patients who undergo pre-stenting, where the risk of 
developing a stent fracture is reduced (Nordmeyer et al., 2011). However, this solution is 
still limited to those patients with suitable implantation sites and the current device does not 
fit all the sizes of patients requiring pulmonary valve treatment. New devices have to be 
developed to offer this minimally invasive procedure to the entire patient population.     
2.2 Next generation device 
Despite the success of the PPVI device, <15% of patients requiring pulmonary valve 
replacement can be treated with the current PPVI device, with the remaining 85% requiring 
open-heart surgery (Schievano et al., 2007a). The majority of these patients are those with 
dilated, dynamic pulmonary arteries in whom the current percutaneous device is too small. 
Importantly, for this morphological problem, animal testing is of very limited use, as there 
are no models that encompass the wide variations of anatomy seen in these patients with 
congenital heart disease. Hence development of a new device to deal with the clinical 
problem and its translation into man is difficult using the conventional pathway of bench 
followed by animal testing.  
Over the last 5 years, a new PPVI device for implantation into the dilated pulmonary artery 
has been developed in collaboration with Medtronic Cardiovascular. The device is made 
from self-expandable nitinol zig-zag rings, held together by a polyester graft in an hourglass 
shape (Fig. 7). The extremities of the stent, with larger diameters, would ensure the 
anchoring of the device against the pulmonary artery, while the central rings, with smaller 
diameter, would act as supporting structures for the valve. Nitinol is a shape memory alloy 
regularly used in bioengineering applications because it combines important qualities such 
  
Fig. 7. New PPVI device and dimensions 
PROXIMAL END DISTAL END
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as biocompatibility, fatigue resistance, and magnetic resonance (MR) compatibility, with the 
peculiar mechanical behaviour to undergo large completely recoverable deformations 
(Petrini et al., 2005). The valve is made of porcine pericardium and is sutured in the central 
portion of the stent-graft. Conventional animal testing and bench testing had been 
undertaken for this device and demonstrated a good performance in the animal model 
(Bonhoeffer et al., 2008). This stent-graft design should guarantee a greater adaptability of 
the device to the wide range of possible implantation site morphologies, with long-term 
fatigue behaviour that dramatically outperforms conventional metals.  
2.2.1 First-in-man application 
During the final stages of the preclinical testing of the new device, a patient presented to our 
Institution requiring pulmonary valve replacement (Schievano et al., 2010a). This patient 
(42-year-old man with congenital heart disease) had previously undergone 4 open-heart 
operations and 2 additional thoracic procedures, and remained highly symptomatic with 
severe pulmonary insufficiency. A further cardiothoracic surgery was considered too high 
risk. In addition, the pulmonary artery was too dilated for the current PPVI device. 
Therefore, the patient was considered for implantation of the new device. An integrated 
strategy to pre-clinical testing, using patient imaging data, computer modelling and 
biomedical engineering was developed to influence the final device design for implantation. 
4D cardiovascular computed tomography (CT) was performed to acquire 3D volumes of the 
implantation site over 10 frames of the cardiac cycle (CT-SOMATOM Definition, Siemens 
Medical Systems) according to previously described methodologies (Schievano et al., 2007a), 
and to measure the 3D deformations in terms of diameter changes at different sections (Fig. 
8a; Schievano et al., 2011). Based on the CT implantation site reconstructions (Mimics, 
Materialise, Belgium), FE models (Fig. 8b) and 3D rapid prototyping (Fig. 8c) models were 
created (Schievano et al., 2007b; Schievano et al., 2010b). Multiple device shapes and sizes 
with varying wire stiffness and configurations were tested in the rapid prototyping models 
and using FE analysis to optimise the anatomical results in the specific patient: the FE 
analysis identified definitive areas of contact between the computer simulated stent-graft 
struts of the customized device and implantation site, predicting likely stability and safe 
anchoring in-vivo. The rapid prototyping models enabled simulation of the clinical 
implantation procedure and helped the implanters decide the approach for optimal device 
delivery. 
The final device (40 mm diameter in the distal and proximal ring, 22 mm diameter in the 
central portion holding the valve) underwent acute and chronic animal tests and bench 
testing. Based on these results, the UK Medicines and Healthcare products Regulatory 
Agency (MHRA), and the local ethical and industrial committees granted approval for the 
use of this device on humanitarian grounds. The patient gave informed consent for the 
procedure and for the anonymous use of his data and images for research.  
PPVI was successfully carried out in this patient with the new device in January 2009. 
During the catheterisation procedure, angiographic studies and balloon sizing of the 
pulmonary trunk were performed and confirmed that the CT and model dimensions were a 
true representation of the patient’s anatomy. The delivery strategy developed from the pre-
procedural trial implantation in the rapid prototyping models was followed and proved safe  
www.intechopen.com
 Finite Element Analysis – From Biomedical Applications to Industrial Developments 176 
 
Fig. 8. a) 3D volume reconstruction of the patient’s implantation site from 4D CT and 
diameter change measurements over the cardiac cycle measured in the 8 selected planes  
(C-L). Examples of b) FE model, and c) plastic rapid prototyping model (guidewire in place) 
of the patient anatomy with the new PPVI device “implanted” to test different positions, 
anchoring, and delivery approaches 
and successful (Fig. 9a). The patient was symptomatically improved following the 
procedure. A post-implantation 4D CT confirmed that the device had the position, shape 
and safe anchoring as predicted by the FE models (Fig. 9b). These post implantation CT 
images were used to reconstruct the stent geometry in-situ and to assess the 3D 
displacements of the device rings over the cardiac cycle. This information was inputted in a 
FE analysis as explained above to predict the likelihood of stent fracture. The patient 
remains well 3 years following the procedure, with no fractures of the stent struts detected 
to date, as predicted by the FE study. 
 
Fig. 9. Lateral view of a) x-ray fluoroscopy, and b) 3D volume CT reconstruction of the new 
PPVI device, 2 days after implantation in the patient 
Whilst such a labour intensive method, which resulted in modifications in the device design 
prior to this first human case, was essential to enable us to safely transfer this new 
a) b) 
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technology into early clinical practice, this approach would not be necessary, or sustainable, 
for each patient in routine clinical practice. Ultimately, the aim for this new PPVI technology 
would be to have a small number of ‘off-the-shelf’ devices with varying sizes and shapes, 
which would be suitable for the vast majority of patients. In order to optimise the number of 
devices necessary to cover the whole range of patients’ morphologies, we used FE analysis 
taking into account patient specific anatomies (Capelli et al, 2010a). 
2.2.2 Optimisation of the next generation device  
FE modelling is a powerful tool to optimise device design without the need for many 
prototypes to be created and tested. In pulmonary valve dysfunction, each patient anatomy 
is completely individual in terms of size, shape and dynamics. FE can help select the most 
appropriate prosthesis for any individual patient taking into account their specific anatomy, 
thus enhancing the safety and success of the procedure. Furthermore, FE analysis can help 
predict how many devices may be needed to cover the whole range of patient morphologies. 
Three different potential designs for the new stent-graft were considered, with equivalent 
central ring diameters (22 mm), but different proximal and distal strut dimensions (Fig. 10; 
Capelli et al, 2010a): the first stent-graft (SG1) resembled the device that had already been 
successfully tested in animals (Bonhoeffer et al, 2008). The second stent-graft (SG2) was 
symmetrical, similar to the device implanted into the patient described in the previous 
paragraph (Schievano et al, 2010a). The third stent-graft (SG3) was similar to SG2, but with 
larger proximal and distal diameters. 1D beam elements were chosen to mesh the stent 
wires (696, 696 and 912 elements for SG1, SG2 and SG3, respectively). Surfaces were created 
in between the struts to model the polyester fabric, which was meshed using membrane 
elements that offer strength in the plane of the element, but have no bending stiffness (3850, 
3408 and 3909 elements for SG1, SG2 and SG3, respectively). A tight, rigid contact was 
assumed to simulate the suture between the stent and the graft. The shape memory alloy 
model implemented in Abaqus code was used to describe the nitinol behaviour of the stent 
wires. A hyperelastic, isotropic constitutive model based on a reduced polynomial strain  
 
Fig. 10. Models of the 3 stent-grafts SG1, SG2 and SG3 designed and tested using FE analysis 
33 mm 
SG1
40 mm 40 mm 
40 mm 
45 mm 
SG2 SG3
45 mm 
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energy density function (C10 = 0.38, C20 = 4.36, C30 = 80.56, C40= -134.72, C50 = 86.24, C60= 
-19.74) was used for the fabric graft material. The material FE models were validated using 
experimental tensile tests carried out for the nitinol wires and fabric samples. The valve was 
neglected in the FE analyses.  
Pre-operative 3D MR data (1.5 T Avanto, Siemens Medical Systems) from 62 patients who 
were morphologically or dimensionally unsuitable for the current Melody™ device were 
used to reconstruct rigid FE models of the implantation sites – rigid 3D shell elements with 
number of elements varying between 7,172 and 13,104 according to the complexity of the 
patient implantation site geometry (Capelli et al, 2010a).  
The 3 stent-grafts’ FE models were placed inside each patient’s outflow tract model, as close 
as possible to the bifurcation, without obstructing the pulmonary arteries. The implantation 
of the devices was carried out by crimping the stent-grafts down to 7 mm diameter (catheter 
dimensions) and then releasing them inside the patients’ outflow tract models 
(Abaqus/Explicit). A general contact algorithm was defined to allow interaction between 
the devices and the arterial wall. The stent-grafts adapted their shape to the implantation 
site of each specific patient (Fig. 11). The diameters after deployment were quantified in the 
proximal, central and distal sections of the stents to judge the safe anchoring of the device 
inside the artery, which was considered optimal if the proximal and distal diameters 
measured less than 80% of the original diameters, according to manufacturer’s 
specifications. Furthermore, the central portion of the device should be >18 mm so that the 
valve sewn inside can be fully deployed.  
 
Fig. 11. Percentage of suitable and not suitable patients for SG1, SG2, and SG3 and examples 
of patients in which device SG2 was virtually implanted. Unsuitable patients are subdivided 
according to the regions of the stent that did not respect the criteria of safe implantation 
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According to these criteria, successful implantation was achieved in 37% of the patients with 
SG1. 42% of the patients would be suitable for the SG2 device and 63% for the SG3 device 
(Fig. 11). Therefore, 37% of those patients who are currently still treated with surgery would 
potentially be suitable for PPVI with a new device. Furthermore, if the dimensions of this 
new device are theoretically increased at the distal end (SG2, as done for the first-in-man 
case) or both proximal and distal ends (SG3), the number of percutaneous procedures would 
increase by a further 5% and 36%, respectively. Importantly, these dimensions would be 
difficult to test in animals because of lack of relevant sizes in these settings. Although animal 
testing remains important, FE modelling could be integrated into preclinical testing to 
predict how such devices behave when implanted into the human situation. 
With the introduction in clinical practice of the new device in 3 sizes, the total number of 
patients requiring pulmonary valve replacement who could benefit from a percutaneous 
approach (current device + 3 sizes of the new device) would be approximately 70%. This 
would potentially have a big impact on the cost benefit for healthcare, by reducing hospital 
stay and improving the speed at which patients can get back to normal daily activities.  
3. Transcatheter aortic valve implantation 
In the past decade, TAVI has been shown to be a feasible and effective option for treatment 
of patients with symptomatic severe aortic stenosis and high operative risks (Leon et al., 
2011; Rodes-Cabau et al., 2010; Smith et al., 2011; Vahanian et al., 2008; Zajarias & Cribier, 
2009). Since the first-in-man experience in 2002 (Cribier et al., 2002), several advances in 
TAVI techniques have led to improved success rates, with acceptable procedure-related 
complication rates (Delgado et al., 2010). To date, 2 different devices have received CE mark 
approval – the balloon-expandable Edwards-Sapien® XT Valve (Edwards Lifesciences, CA, 
USA) and the self-expandable CoreValveReValving System® (Medtronic) – with many other 
devices emerging into the market (Fig. 12). The encouraging mid- and long-term results of  
 
Fig. 12. TAVI Edwards-Sapien® Valve and the self-expandable Medtronic CoreValve 
ReValving System®  
(http://mail.c2i2.org/web10-06/transcatheter_aortic_valve_implantation.asp) 
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this technique, together with increased patient comfort, shortened intensive care and 
hospital stay, and the avoidance of cardiopulmonary bypass, make this non-surgical 
technique extremely appealing (Ussia et al., 2009).  
Accurate multidisciplinary pre-procedural evaluation of patients who are considered 
candidates for TAVI is mandatory to plan the most adequate treatment and to minimise 
peri- and post-procedural complications (Smith et al., 2011; Vahanian et al., 2008). However, 
in this emerging field, several issues remain a source of debate. Device sizing and 
positioning are the main challenges, but vascular complications, electrical conduction 
abnormalities and post-procedural aortic regurgitation still remain major safety concerns. In 
addition, according to the current position statement, TAVI is indicated only in patients 
with severe symptomatic aortic stenosis, and who are considered at high or prohibitive risk 
for conventional surgery (Ussia et al., 2009, Leon et al., 2011).  
Extending TAVI to patients who still undergo conventional surgery poses new challenges, 
both for clinicians and device manufacturers, but “within 10 years, with further 
improvement of the devices and procedures, and depending on the long-term results of 
upcoming controlled trials in a broad population, TAVI may become the treatment of choice 
in a majority of patients with degenerative aortic stenosis” (Cribier, 2009). Indeed, highly 
experienced centres have already demonstrated the feasibility of TAVI in failed 
bioprosthetic heart valves (valve-in-valve procedure) in patients considered at very high-
risk or ineligible for surgery (Webb et al., 2010). Previous surgical valve implantations 
represent a well-defined landmark with rigid boundaries that increase ease of positioning 
and anchoring, thus making patients with bioprosthetic valves ideal candidates for TAVI 
(Walther et al., 2011). Conversely, younger patients, with less severe aortic valve stenosis or 
with valve insufficiency, often present implantation sites with different anatomical and 
dynamic characteristics that generate procedural and device related hurdles, which means 
that such patients are currently not suitable for or offered TAVI.  
Combining patient-specific imaging data and computational modelling offers a new method 
to obtain additional, predictive information about responses to cardiovascular device 
implantation in individual patients (Schoenhagen et al., 2011; Taylor & Figueroa, 2009). FE 
analyses were performed to explore the feasibility of TAVI using a model of the Edwards-
Sapien® device in specific patient morphologies which are currently borderline cases for a 
percutaneous approach. This method can help in both refining patient selection and 
characterising device mechanical performance, overall impacting on procedural safety and 
success in the early introduction of TAVI devices in new patient populations.  
3.1 Patients with previously implanted bioprosthetic valves 
Four patients with different stenotic bioprosthetic valves previously implanted (patients A – 
23 mm Carpentier-Edwards Perimount Magna valve, Edwards Lifesciences; B – 23 mm 
Soprano™ valve, Sorin Biomedica Cardio, Italy; C – 25 mm Carpentier-Edwards Perimount 
valve, Edwards Lifesciences; D – 25 mm Epic™ valve, St Jude Medical, MN, USA) and who 
were referred for surgical replacement of their failing bioprosthetic valve were analysed 
(Bosi et al., 2010; Migliavacca et al., 2011). Data about the anatomy of the aortic root, 
coronary arteries, AV leaflets and bioprostheses were acquired using CT imaging (CT-
SOMATOM Definition) and these data were used to reconstruct 3D geometries for FE 
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models of the selected patients’ implantation sites (Fig. 13). The aortic roots were assumed 
to be 2 mm thick, with density equal to 1,120 kg/m3 (Conti et al., 2010) for all models and 
meshed with 3D triangular shell general-purpose elements (Table 2). To describe the 
mechanical behaviour of the aortic roots, Mooney-Rivlin hyperelastic behaviour was 
adopted incorporating experimental stress-strain data for the ascending aorta (Okamoto et 
al., 2002) and taking into account the pre-stretching of the aortic root due to the aortic 
pressure during the cardiac circle.  
 
Fig. 13. CT image reconstruction of the selected patients’ aortic wall with previously 
implanted bioprosthetic valves. FE models of the deployment balloon and TAVI stent are 
placed inside the implantation site models 
Part Elements 
Patient-specific model  
 A 6,875 
 B 8,675 
 C 11,325 
 D 8,347 
Bioprosthesis (stent + leaflets)  
 Perimount Magna 44,048 + 29,021 
 Soprano 51,372 + 28,667 
 Perimount 44,048 + 29,021 
 Epic 51,372 + 28,667 
TAVI device  
 Sapien stent 192,920 
 Balloon 8,160 
Table 2. Number of mesh elements for the different parts involved in the FE simulations 
The metal frames of the 4 bioprosthetic valves were reconstructed from the CT images to 
identify their position inside the patients’ outflow tracts. The bioprosthetic valve geometries 
were re-drawn using CAD software (Rhinoceros) to recreate a complete model of the 
corresponding commercial device used in the patients, and then placed in the same position 
as that identified from CT images. Connector elements were used to link the bioprosthetic 
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valves with the aortic vessels to mimic the suture between the ring and the aortic root. Each 
prosthesis included different frame structures, sewing rings and artificial valve leaflets. The 
frames (metallic and polymeric) were meshed with 8-node linear hexahedral elements with 
reduced integration (Table 2), and modelled using an elasto-plastic constitutive behaviour 
obtained from the manufacturer’s data. Bovine and porcine valve leaflets were meshed with 
4-node, quadrilateral, shell elements with reduced integration and large-strain formulation 
(Table 2), while the material properties were simplified using a linear, elastic model (Lee et 
al., 1984; Zioupos et al., 1994). Calcification of the leaflets was created by increasing Young’s 
modulus and thickness in the region of the commissures (Loree et al., 1994), where a weld 
constraint was also applied (Schievano et al., 2009): 16 connector elements per commissure 
were added. An axial, rigid behaviour was assigned to the connectors, allowing them to 
maintain a fixed distance between the 2 nodes until a threshold force was reached – equal to 
0.92 N (Loree et al., 1994) along the direction joining the 2 nodes – and then fail after this 
threshold value was reached, mimicking calcification failure. The thickening and welding of 
the failing valve leaflets produced aortic valve geometric orifice areas equal to those 
measured in the selected patients (1.2 cm2 for A and B, and 1.4 cm2 for C and D).   
The Edwards-Sapien® stent is characterised by 12 units, each formed by 4 zigzag elements 
(Fig. 12). A vertical bar divides each unit and a perforated bar is positioned every 4 units. 
The CAD geometry of this stent was reproduced with a height, internal diameter and 
thickness of the expanded stent equal to 16.0, 25.4 and 0.3 mm, respectively.  The stent was 
mashed with hexahedral elements, following mesh sensitivity analysis. It is made of 
stainless steel which was modelled using Von Mises plasticity behaviour from manufacturer 
data.  
A semi-compliant balloon was designed to resemble the commercial balloon used in clinical 
practice (Z MED II™, NuMed Inc, NY, USA) and placed inside the TAVI stent in order to 
deploy the device (Capelli et al, 2010b; Gervaso et al., 2008). The balloon was meshed with 
0.03 mm thick membrane elements, and a homogeneous, isotropic, linear-elastic Nylon11 
was adopted according to manufacturer data. The stent was crimped down onto the balloon, 
from its original configuration to catheter dimension (8 mm diameter), using a coaxial 
cylindrical surface. 
The stent-balloon system was placed into the aortic root models according to the judgment 
of 2 clinicians (Fig. 13). Large deformation analysis of stent deployment in the patients’ 
implantation sites, performed with Abaqus/Explicit, was divided in 2 different steps: 
balloon pressurisation with resulting stent expansion in the aortic root, and balloon 
deflation with subsequent stent recoil. In all patients, the implantation site model 
extremities (upper and lower aortic sections and coronary terminal sections) were 
constrained in all directions (circumferential, radial and longitudinal) in order to mimic the 
connection with biological structures. Boundary conditions on the balloon were placed to 
mimic the bond with the catheter. 
Contact properties were defined to describe the interactions encountered in these multi-part 
analyses. Interactions included contact between surfaces belonging to balloon and TAVI 
stent, balloon and bioprosthetic aortic valve leaflets, TAVI stent and bioprosthetic aortic 
valve, bioprosthetic aortic valve and aortic wall. Friction between Nylon and stainless steel 
was included in the model with coefficient equal to 0.25 (De Beule et al., 2008). 
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Mechanical performance of the stent and the impact of the TAVI device into patients’ 
implantation sites were evaluated by analysing: stent configurations at the end of balloon 
inflation, stent recoil after balloon deflation, stent and arterial stress distribution and peak 
values at the end of the expansion and recoil phases, degree of aortic valve stenosis assessed 
according to the post-TAVI geometrical orifice area, and evaluation of coronary artery 
obstruction. 
At the end of all simulations, the TAVI stent was virtually implanted inside the 
bioprostheses of the patient-specific aortic root model, with a position that was found in 
good agreement with available images from a TAVI follow-up case (Fig. 14, Webb et al., 
2010). 
 
Fig. 14. Result from the FE simulation of TAVI stent in a Carpentier-Edwards bioprosthesis, 
resembling the CT image reconstruction of a patient’s TAVI in the same bioprosthetic valve 
published by Webb et al., 2010 
After deployment, the stent assumed an asymmetrical configuration in the longitudinal 
direction, more expanded in the distal part. There was no contact with the native aortic wall 
and/or other cardiac structure. This was also demonstrated by the low stresses (<0.1 MPa) 
measured in the aortic wall, showing how the previously implanted bioprostheses act as a 
scaffold for the TAVI stent. After balloon deflation, the bioprosthetic valve leaflets partially 
recoiled forcing the TAVI stent to a more symmetrical shape, which could be defined almost 
cylindrical in all cases (Fig. 15). Maximum recoil was measured in the distal sections for all 
patients (A = 17.0%; B = 13.2%; C = 11.7%; D = 10.8%) with absent or low recoil at the level 
of the bioprosthetic valves’ annulus.  
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Fig. 15. TAVI stent final configuration (end of balloon deflation) in the patients’ models 
At the end of both the expansion and recoil phases, for all models, non-uniform stress 
distribution was recorded on the stent struts with the highest Von Mises stresses occurring 
at the strut junctions with the vertical bars (Fig. 16). At the same locations material 
plasticisation was reached that guaranteed final open configurations. If we compare the 
results from the patient-specific simulations with those of a stent uniformly deployed in a 
cylinder, which is the idealised implantation site used in conventional preclinical testing of  
 
Fig. 16. Von Mises stress distribution in the TAVI stent after balloon deployment and 
deflation in a cylindrical configuration and in patient C 
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such devices, the maximum stress reached in the stent deployed in the patients was 
significantly higher than the stress in the stent deployed in the cylinder (443 vs 270 MPa). In 
addition, the stent was uniformly deployed in the cylinder during the entire simulation: 
recoil between the steps of balloon inflation and deflation was low (1.5%) and uniform along 
the stent length. The non-uniform shape of the deployed configuration in the patients and, 
therefore, the asymmetric stress distribution might cause long-term stent failure due to the 
pulsatile loading conditions during the cardiac cycle that are not seen during conventional 
pre-clinical tests (Schievano et al., 2010b). 
After simulated TAVI, the connectors modelling calcification of the leaflet commissures 
were all broken, thus increasing the aortic valve geometrical orifice area to 3.43, 3.60, 3.72, 
and 3.73 cm2 for patient A, B, C and D respectively. Minimum distances between implanted 
TAVI device and coronary arteries (right and left) after the deflation of the balloon were 
10.9, 11.4, 10.5, and 5.5 mm for patient A, B, C and D respectively, with no direct obstruction 
of the ostia. 
In all cases, the virtual implantation of the TAVI device predicted a successful procedural 
outcome with an orifice area larger than the pre-implantation stenotic area, and no 
interference with other cardiac structures. Furthermore, patient-specific FE analyses showed 
no fractures of the stent immediately post-implantation. These methodologies might help 
engineers to better understand the mechanical behaviour of the stent when interacting with 
a wide variety of potential anatomies and, therefore, to optimise the device design for 
different potential clinical applications before actual procedures are performed.  
3.2 Patients with aortic incompetence 
A patient (E) diagnosed with congenital, moderate aortic valve stenosis, which was treated 
after birth with aortic balloon valvuloplasty, was selected. At 21 years of age, this patient 
was referred for surgical repair of her severe aortic valve regurgitation. FE model of TAVI in 
this patient specific native aortic root and valve leaflets was performed using the same TAVI 
stent model described above.  
CT image data (CT-SOMATOM Definition) from the patient corresponding to mid-systole 
(i.e. open aortic valve leaflets) were elaborated in the image post-processing software 
Mimics. A 3D model of the aortic root, coronary arteries and valve leaflets was obtained for 
the patient (Fig. 17). The native structures were meshed with 3D triangular shell general-
purpose elements (18,890 elements). Aortic wall and native valve leaflets were assumed to 
be respectively 2 and 0.5 mm thick (Conti et al., 2010) with density equal to 1,120 kg/m3, 
and Mooney-Rivlin hyperelastic constitutive law was adopted to describe the material 
behaviour. 
In model E, the TAVI stent/balloon was placed in 3 different positions within the aortic root 
to test the influence of the landing zone into safe anchoring, the interference with other 
cardiac structures, such as the mitral valve and the atrioventricular node, and potential 
occlusion of the coronary arteries. First, the central section of the stent was placed aligned to 
the leaflet commissures (EM; Fig 17), then it was moved 4.2 mm proximally towards the left 
ventricle (EP; Fig. 17), and 4.2 mm distally towards the aortic arch (ED; Fig. 17). 
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Fig. 17. Balloon and TAVI stent in the 3 analysed positions inside the native aortic valve: in 
correspondence of the leaflet commissures (EM); moved 4.2 mm proximally towards the left 
ventricle (EP); and, 4.2 mm distally towards the aortic arch (ED). 
The same loading and boundary conditions as those described above for the study of TAVI 
in bioprosthetic valves were adopted. Also, the same quantities of interests were measured. 
In this patient, at the end of stent deployment and balloon deflation, the device assumed an 
asymmetrical configuration for all tested positions, more open distally than proximally (Fig. 
18). In all 3 cases, the interaction between the TAVI device and the native implantation site 
was well confined within the left ventricular outflow tract and aortic root portion of the 
patient’s morphology, thus reducing the potential risk of heart block and mitral valve leaflet 
entrapment. The stent implanted in this patient in the most distal position was the closest to 
the right coronary artery (3.1 mm). The TAVI device caused no direct obstruction of the 
coronary orifice; however, further fluid-dynamic studies could enhance our understanding 
of the effects of the TAVI device placement to the coronary flow.  
 
Fig. 18. TAVI stent final configuration (end of balloon deflation) in the 3 simulated positions. 
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At balloon deflation, the interaction with the native aortic valve and wall caused high recoil 
in the proximal section of the stent for all 3 tested positions EM = 14.9%; model EP = 20.2%; 
model ED = 11.4%. This may be considered a potential cause for obstruction of the left 
ventricular outflow tract and result in potential dislodgment of the TAVI device from its 
original position. However, the final geometric orifice areas for the analysed patient in the 3 
positions EM, EP, and ED – 4.7, 3.7 and 5.3 cm2 respectively – were same size or larger that the 
initial orifice area = 3.7 cm2. 
Direct interaction of TAVI stent with native tissue had impacts both on the device and on 
the implantation site. After recoil, the geometrical configuration of the stent was not 
uniform, with an asymmetrical stress distribution (max 477 MPa for EP). The ultimate stress 
value for the stent material (stainless steel AISI 316L ultimate strength = 515 MPa) was not 
reached; this means that no stent fractures were seen immediately after deployment. 
However, pulsatile compressions during cardiac cycle could affect the long-term 
performance of this stent due to the dynamic nature of the native, non-calcified implantation 
site. This may be particularly relevant for model EP where the distal portion of the device 
was in direct contact with the active muscular portion of the left ventricular outflow tract.  
The expansion of the TAVI stent within native tissue also caused high maximum principal 
stresses (1 MPa) in the arterial wall, in particular in the region of the leaflets for model ED, at 
commissure level (Fig. 19). This might induce damage or stimulate remodelling (e.g. 
stenosis).  
A careful balance between interrelated and sometimes contradictory requirements has to be 
achieved for optimal TAVI positioning and outcomes such as relief of valve dysfunction and 
safe anchoring with no tissue damage, no coronary obstruction, no interference with other 
cardiac structures and no device failure in both short- and long-term. Patient specific FE 
analysis can be used to help in this process of optimisation and represent an additional 
assessment tool for the selection of patients for TAVI.  
 
Fig. 19. Maximum principal stress distribution in the native aortic valve leaflets and aortic 
root after balloon deflation in models EP, EM and ED. 
4. Conclusion 
Engineering and computational methodologies, together with state of the art imaging 
technologies, can be used to replicate patient specific patho-physiological conditions in 
virtual models. Combining patient specific imaging data and computational modelling can 
improve our understanding of heart structures and the way devices interact with them. 
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Therefore, advanced FE analyses can become a fundamental tool during preclinical testing 
of new biomedical devices that could shorten the time for device development, minimise 
animal experimentation, and ensure greater patient safety during the delicate phase of 
testing clinical feasibility of novel cardiovascular technologies.  
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